Liver cancer stage 4 Doctors Abroad — Page 3

Associate Professor Dr. Yusuf Acikgoz brings international oncology experience from Ohio State University to Lokman Hekim University Ankara Hospital.

• Specialized in Medical Oncology with extensive training in Turkey and the US
• Participated in Phase III clinical trials for advanced cancer treatments
• Member of American Society of Clinical Oncology (ASCO)
• Certified in Good Clinical Practice and human subjects research

32 years of experience specializing in liver and pancreatic cancers – Dr. Ben-haim is among Israel's top gastrointestinal oncology surgeons at Sourasky Medical Center.

• Expert in Whipple surgery for complex cases
• Focuses exclusively on gastrointestinal cancers
• Performs advanced interventions for cancer management

Prof. Wolfgang Köstler specializes in targeted cancer therapies, focusing on breast and gynecologic malignancies. He combines decades of clinical expertise with cutting-edge research.

• Over 22 years of experience of experience in medical oncology
• Expert in personalized cancer medicine and immunotherapy
• Senior consultant at Wiener Privatklinik
• Associate Professor at Medical University of Vienna
• Published research on biomarker development and tumor biology

Associate Professor Tahsin Ozatli specializes in breast, lung, and gastrointestinal cancers at Istinye Liv University Hospital.

• Over 2016 years of experience of experience in oncology
• Internal Medicine Specialist at Malatya State Hospital
• Served at Ankara Oncology Clinic and Erzurum Regional Training Hospital
• Studied medicine at Selcuk University

49 years of experience in immunology with focus on virotherapy – Dr. Jaunalksne specializes in cutting-edge immunological treatments for liver cancer at Pallas Clinic.

• Leads the Clinical Immunology Center at Pauls Stradins Clinical University Hospital
• Trained at Riga Medical Institute and completed an Internal Medicine internship
• Focuses on virotherapy, a novel approach in cancer treatment

Dr. Liuying leads the Oncology Ward at Jinshazhou Hospital, Guangzhou University of Chinese Medicine. Clinical focus includes hepatocellular carcinoma, cholangiocarcinoma, and lung and colorectal cancers. Dr. Liuying has special expertise in melanoma and melanoma liver metastasis. Interventional skills include MWA, RFA, cryoablation, and radioactive seed implantation for non-vascular, minimally invasive tumor ablation.

Research: participated in two Guangdong Provincial science and technology projects. Contributed to the 2014 Expert Consensus for Thermal Ablation of Primary and Metastatic Lung Tumors. Published in the Chinese Journal of Lung Cancer. Compiled Selected Cases of Microwave Ablation for Lung Tumors and Selected Cases of Microwave Ablation for Liver Tumors.

Appointments: Standing Committee Member, Youth Committee of Intra-Tumor Brachytherapy Medicine, China Medical Education Association. Standing Committee Member, Minimally Invasive Interventional Medicine Professional Committee, Guangdong Primary Medical Association.

Head of the Gastrointestinal Cancer Center at Hadassah Medical Center – directly oversees complex liver cancer cases. His 33-year career is entirely focused on oncology and radiotherapy.

• Board-certified in both medical oncology and radiotherapy
• Trained and built his career at Hadassah University Hospital in Jerusalem
• Active member of the national Committee for Gastrointestinal Cancer
• Experienced in the latest systemic therapies and targeted radiation
• Senior physician role involved in training other oncologists

Professor Shixin Liu, MD, PhD, is the Discipline Leader of the Oncology Center. He is the former President of Jilin Provincial Cancer Hospital and former Director of the Cancer Prevention and Treatment Research Institute. He is a second-level professor and doctoral supervisor. He has received the State Council Special Government Allowance, the 4th National Famous Doctor (Outstanding Contribution) award, and the Model of Medical Ethics honor.

He specializes in the comprehensive diagnosis and treatment of malignant tumors. His focus is precision radiotherapy for thoracic and abdominal cancers. He is skilled in IMRT, VMAT, and SBRT for lung, esophageal, breast, and rectal cancers.

His leadership roles include Vice Chair of CMA Radiation Oncology, CACA Radiotherapy, and CACA Particle Therapy. He serves on the CSCO Standing Committee and as Vice Chair of the CSCO Radiation Oncology Expert Committee. He is Vice Chair of CPAM Radiation Oncology and a Standing Committee member of CSMEA. He chairs the Jilin Medical Association Radiation Oncology branch. He is on the editorial boards of the Chinese Journal of Radiation Oncology and the Practical Journal of Cancer.

Professor Gul Alco specializes in radiation oncology at Medipol Acibadem District Hospital, with over 31 years of experience of experience in the field.

• Professor at Istanbul Medipol University's Department of Radiation Oncology
• Completed residency at Kadir Has University's School of Medicine
• Associate Professor and later Professor at Demiroglu Bilim University
• Worked at Şişli Florence Nightingale Hospital and Gayrettepe Florence Nightingale Hospital

Nail Paksoy brings extensive experience from Istanbul University Oncology Institute and now serves as an Assoc. Prof. at Medipol Bahçelievler Hospital.

• Specializes in liver cancer treatment with a focus on advanced stages
• Board-certified in Medical Oncology by ESMO
• Contributed to eight international clinical trials in oncology
• Published multiple research papers on metastatic cancers

Specialized in advanced laparoscopic and oncological cancer surgery – Dr. Al brings extensive training from top Turkish medical institutions.

• Trained at Istanbul University's Cerrahpaşa Faculty of Medicine
• Expertise in laparoscopic bariatric and anti-reflux techniques
• Over 16 years of experience of surgical experience

Specialist in minimally invasive liver cancer surgery at Medical Park Goztepe Hospital, focusing on reducing patient recovery time.

• Author of over 40 medical documents
• Faculty member at Bahçeşehir University's Faculty of Medicine
• Member of the prestigious American College of Surgeons
• Also a member of the Liver Transplantation Society
• Trained at Cukurova and Ege Universities

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Specializes in complex cancer surgeries, including liver, pancreatic, and bile duct procedures at Büyük Anadolu Hospitals.

• Expert in oncological surgery with a focus on gastrointestinal cancers
• Performs advanced bariatric and metabolic surgeries
• Skilled in breast and thyroid cancer operations